These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31603597)

  • 21. Analysis of the factors influencing the therapeutic effects of onychomycosis.
    Zheng Y; Wu Y; Chen H; Zhu Z; Liu L; Zeng J
    J Tongji Med Univ; 2001; 21(3):259-62. PubMed ID: 12539595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age as limiting factor of the efficacy of itraconazole for treatment of onychomycosis.
    Fiallo P; Cardo PP
    Mycoses; 2001; 44(5):191-4. PubMed ID: 11486457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.
    Ranawaka RR; de Silva SH
    Int J Dermatol; 2017 Feb; 56(2):202-208. PubMed ID: 27813064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of extensive onychomycosis in aged patients].
    Maleszka R; Adamski Z
    Wiad Parazytol; 2001; 47(4):817-22. PubMed ID: 16886433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onychomycosis in the elderly : drug treatment options.
    Loo DS
    Drugs Aging; 2007; 24(4):293-302. PubMed ID: 17432924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE; Cantrell W; Lin T
    J Drugs Dermatol; 2018 Feb; 17(2):175-178. PubMed ID: 29462225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
    Khosravi AR; Mansouri P
    Mycopathologia; 2001; 150(1):9-13. PubMed ID: 11392568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Itraconazole pulse therapy for the treatment of Candida onychomycosis.
    Gupta AK; De Doncker P; Haneke E
    J Eur Acad Dermatol Venereol; 2001 Mar; 15(2):112-5. PubMed ID: 11495516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up study of onychomycosis: cure rate and dropout rate with oral antifungal treatments.
    Iozumi K; Hattori N; Adachi M; Kaneko T; Shimozuma M; Tamaki K
    J Dermatol; 2001 Mar; 28(3):128-36. PubMed ID: 11349463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study.
    Tietz HJ; Hay R; Querner S; Delcker A; Kurka P; Merk HF
    Mycoses; 2013 Jul; 56(4):414-21. PubMed ID: 23586591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of antifungal agents in onychomycoses.
    Debruyne D; Coquerel A
    Clin Pharmacokinet; 2001; 40(6):441-72. PubMed ID: 11475469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida onychomycosis in HIV infection.
    Tosti A; Piraccini BM; Lorenzi S; D'Antuono A
    Eur J Dermatol; 1998; 8(3):173-4. PubMed ID: 9653014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
    Havu V; Brandt H; Heikkilä H; Hollmen A; Oksman R; Rantanen T; Saari S; Stubb S; Turjanmaa K; Piepponen T
    Br J Dermatol; 1997 Feb; 136(2):230-4. PubMed ID: 9068738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of onychomycosis with oral antifungal agents.
    Iorizzo M; Piraccini BM; Rech G; Tosti A
    Expert Opin Drug Deliv; 2005 May; 2(3):435-40. PubMed ID: 16296765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of nondermatophyte mold and Candida onychomycosis.
    Tosti A; Piraccini BM; Lorenzi S; Iorizzo M
    Dermatol Clin; 2003 Jul; 21(3):491-7, vii. PubMed ID: 12956201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
    Piraccini BM; Sisti A; Tosti A
    J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
    J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study.
    Sipponen P; Sipponen A; Lohi J; Soini M; Tapanainen R; Jokinen JJ
    Mycoses; 2013 May; 56(3):289-96. PubMed ID: 23131104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.